You're reading the free version. Trader adds the live tape and alerts.
Start tracking
COCP Award Disclosure
Sapirstein James · SEC Form 4 · Filed Jun 3, 2026
Award
Calculated transaction value
$0
Sapirstein James Chief Executive Officer
COCP
Transaction date
Jun 3, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed same day
COCP daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (Right to Buy) on Common Stock
- Quantity / price
- 235,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-027054
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cocrystal Pharma, Inc. COCP Current | Award | Jun 3, 2026 | $0 |